Rituximab as first-line adjuvant therapy for pemphigus: Retrospective analysis of long-term outcomes at a single center

Publication date: April 2018
Source:Journal of the American Academy of Dermatology, Volume 78, Issue 4
Author(s): Keshavamurthy Vinay, Simone Cazzaniga, Kyle T. Amber, Laurence Feldmeyer, Luigi Naldi, Luca Borradori




http://ift.tt/2FJlZEU